Weekly cisplatin fails to reduce acute toxicity in advanced head and neck cancer
Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given…
Shortages of crucial cancer medications continue to impact US healthcare
Today, the National Comprehensive Cancer Network® (NCCN®)-an alliance of leading cancer centers-published updated data on the current impact…
Autophagy modulation emerges as a strategy against cisplatin-resistant gastric cancer
Drug resistance remains one of the greatest obstacles to successful treatment of gastric cancer, limiting the long-term effectiveness…
Clusterin inhibition offers new hope for treating cervical gastric-type adenocarcinoma
Gastric-type adenocarcinoma (GAS) is one of the most aggressive non-human papillomavirus (HPV)-associated cervical adenocarcinomas and remains especially difficult…
Study reveals long-term health risks after chemotherapy for testicular cancer
A large, multi-center study recently published online in the Journal of the National Comprehensive Cancer Network (JNCCN) provides…
Fusobacterium nucleatum-reprogrammed adipocytes promote tumor cisplatin resistance through the CCL2-CCR2 axis in the necrotic metastatic neck nodes of head and neck carcinoma | Cell Communication and Signaling
Hanai N, Ozawa T, Hirakawa H, et al. The nodal response to chemoselection predicts the risk of recurrence…
Scientists uncover brain circuit that turns cravings into eating behavior
Scientists uncovered how the brain’s bed nucleus of the stria terminalis acts as a master switchboard, merging reward…